- Home
- CECO vs JANX Comparison
CECO vs JANX Comparison
Compare CECO & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CECO
- JANX
- Stock Information
- Founded
- CECO 1966
- JANX 2017
- Country
- CECO United States
- JANX United States
- Employees
- CECO N/A
- JANX N/A
- Industry
- CECO Pollution Control Equipment
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- CECO Industrials
- JANX Health Care
- Exchange
- CECO Nasdaq
- JANX Nasdaq
- Market Cap
- CECO 1.7B
- JANX 1.4B
- IPO Year
- CECO N/A
- JANX 2021
- Fundamental
- Price
- CECO $49.33
- JANX $23.56
- Analyst Decision
- CECO Strong Buy
- JANX Strong Buy
- Analyst Count
- CECO 4
- JANX 10
- Target Price
- CECO $46.25
- JANX $79.50
- AVG Volume (30 Days)
- CECO 437.5K
- JANX 634.3K
- Earning Date
- CECO 10-28-2025
- JANX 11-05-2025
- Dividend Yield
- CECO N/A
- JANX N/A
- EPS Growth
- CECO 277.71
- JANX N/A
- EPS
- CECO 1.43
- JANX N/A
- Revenue
- CECO $656,167,000.00
- JANX $439,000.00
- Revenue This Year
- CECO $39.13
- JANX N/A
- Revenue Next Year
- CECO $9.94
- JANX $130.50
- P/E Ratio
- CECO $34.59
- JANX N/A
- Revenue Growth
- CECO 15.73
- JANX N/A
- 52 Week Low
- CECO $17.57
- JANX $21.97
- 52 Week High
- CECO $50.41
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- CECO 64.57
- JANX 46.70
- Support Level
- CECO $47.12
- JANX $23.62
- Resistance Level
- CECO $50.00
- JANX $25.35
- Average True Range (ATR)
- CECO 2.12
- JANX 1.12
- MACD
- CECO -0.19
- JANX 0.09
- Stochastic Oscillator
- CECO 85.85
- JANX 36.16
About CECO CECO Environmental Corp.
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.